Search
for

    Glossary Upadacitinib

    medication that inhibits enzymes to treat autoimmune conditions

    Upadacitinib is a medication that belongs to a class of drugs known as Janus kinase (JAK) inhibitors. It works by blocking specific enzymes involved in the inflammatory process, making it useful for treating autoimmune conditions like rheumatoid arthritis and, more recently, certain types of alopecia (hair loss).

    Sort by

    Research 30 of 261

    1. Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review Acta Dermato Venereologica · 2023 · 14 citations
    2. Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report Journal of the European Academy of Dermatology and Venereology · 2023 · 12 citations
    3. Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report SAGE Open Medical Case Reports · 2023 · 10 citations
    4. Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata Dermatology and therapy · 2023 · 9 citations
    5. Upadacitinib for the management of severe alopecia areata in adolescent patients: a single-centre retrospective study Clinical and Experimental Dermatology · 2024 · 7 citations
    6. Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report SAGE open medical case reports · 2022 · 7 citations
    7. Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study Journal of the American Academy of Dermatology · 2023 · 6 citations
    8. Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review Reumatismo · 2024 · 5 citations
    9. Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib Frontiers in Immunology · 2024 · 5 citations
    10. Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient Journal of Allergy and Clinical Immunology Global · 2024 · 5 citations
    11. Drug-Induced Alopecia Areata From Upadacitinib Cureus · 2024 · 3 citations
    12. Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series JAAD case reports · 2023 · 3 citations
    13. Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review Journal of Clinical Medicine · 2025 · 2 citations
    14. Concomitant management of alopecia universalis and ulcerative colitis with upadacitinib Internal Medicine Journal · 2024 · 2 citations
    15. Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review Clinical Cosmetic and Investigational Dermatology · 2025 · 1 citations
    16. Improvement of Recalcitrant Dissecting Cellulitis of the Scalp After a Trial of Upadacitinib Curēus · 2024 · 1 citations
    17. Upadacitinib for the treatment of refractory alopecia areata in pediatric patients: A retrospective study Journal of the American Academy of Dermatology · 2025 · 1 citations
    18. Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib Anais Brasileiros de Dermatologia · 2026
    19. Upadacitinib for Severe Alopecia Areata in Adults and Adolescents JAMA Dermatology · 2026
    20. Long-term Efficacy and Safety of Upadacitinib in the Treatment of Alopecia Areata: A Retrospective Study Journal of the American Academy of Dermatology · 2026
    21. Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review Frontiers in Immunology · 2026
    22. Successful Treatment of Extensive Ritlecitinib-Refractory Alopecia Areata with Upadacitinib Clinical Cosmetic and Investigational Dermatology · 2026
    23. Successful Treatment of Extensive Ritlecitinib-Refractory Alopecia Areata with Upadacitinib DOAJ (DOAJ: Directory of Open Access Journals) · 2026
    24. Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications Journal of Skin and Sexually Transmitted Diseases · 2026
    25. Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis Clinical Journal of Gastroenterology · 2026
    26. Upadacitinib is effective in treating psoriasis combined with lichen planus: a case report Frontiers in Medicine · 2026
    27. Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control Clinical Cosmetic and Investigational Dermatology · 2026
    28. Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series Reports — Medical Cases Images and Videos · 2026
    29. Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports Dove Medical Press (Taylor and Francis Group) · 2026
    30. Upadacitinib: A New Weapon for the Treatment of Twenty-Nail Dystrophy Indian Journal of Dermatology · 2026